MUNICH--GPC, a second-generation genomics-based drug discovery company, has created a US subsidiary, GPC USA, based in Princeton, NJ. John Richard has been named US business development advisor and Gregory Hamm is vice-president of bioinformatics and US site head.
Richard's background includes developing strategic alliances in genomics, drug discovery, and drug delivery. He has been executive vice-
president at Sequus Pharmaceuticals and head of business development at Vivus and at Genome Therapeutics.